Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,609.78
(
0.13%
)
US TECH 100
29,875.60
(
0.56%
)
Dow Jones
51,307.79
(
0.45%
)
Brent Oil
95.27
(
-0.73%
)
Bitcoin
67,402.32
(
-5.56%
)
News Focus
News Focus
Post# of 519097
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 148
Posts 26302
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: XenaLives post# 183505

Saturday, 03/02/2019 2:42:48 PM

Saturday, March 02, 2019 2:42:48 PM

Post# of 519097
dadofmarcmax, What do you think about the following:

ANAVEX 2-73 also shows synergistic activity with three generations of epilepsy drugs currently on the market:
ETS (Zaronrin®), VPA (Depakene®) and Gabapentin (Neurontin®)

https://anavex.com//wp-content/uploads/ANAVEX-2-73-as-a-Potential-Treatment-for-Rett-Syndrome.pdf

Good luck and GOD bless,

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News